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In the months since the publication of our manuscript, an important technical issue has come to our attention. 
In subsequent work, we learned that the anti-integrin 4 antibody (Serotec MCA1230) used in the experiments detailed 
in Figs. 8 C, 9 B, and 10 contained 0.09% sodium azide as a preservative, which can potentially contribute to cell death. 
The observed inhibition of erythroid cell proliferation by this antibody could have been due at least in part to the azide. 
We do not feel that this detail minimizes the conclusion of our work that 41 integrin protects terminally differentiating 
erythroid progenitor cells from apoptosis, but we do wish to bring it to your attention. The role of 41 integrin in 
erythropoiesis was made clear in the following experiments that did not utilize this antibody preparation:
  In Fig. 8 B, the role of 41 integrin in mediating adhesion of erythroid progenitors 
 to  fi  bronectin is shown using mutant fi  bronectin fragments, without the use of any antibody.
  In Fig. 8 C, the addition of the azide-containing 4 antibody had no effect on the 
  number of cells adhering to the V0 fragment.
  In Fig. 9 A, the role of 41 integrin in mediating proliferation of terminally differentiating 
  erythroid progenitors is seen without the use of any antibody.
  In Fig. 9, C and D, the specifi  c effect of 41 integrin during the second phase of the 
  culture period is seen without the use of any antibody.
We feel that this additional information could be helpful to those also utilizing in their research function-blocking 
antibodies to cell surface adhesion receptors.